2012 glutathione alzheimer's disease five authors Frontiers 2012 glutathione alzheimer's disease five

6 (4) dmm.010975: 977992

Low total GSH and high homocysteine levels are considered as novel risk markers for acute stroke severity, and low total and reduced GSH levels may be potential risk markers for stroke severity and insufficient functional independence in large-artery atherosclerosis (157, 158)

(3) Preventing Alzheimer disease (AD) is paramount to helping patients with DS as they age

Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription

Toxicol Appl Pharmacol 447:116072 Singh A, Narsinghani T (2023) Bioanalytical method validation: a comprehensive assessment of various regulatory guidelines